Market Closed -
Swiss Exchange
11:30:44 2024-05-03 am EDT
|
5-day change
|
1st Jan Change
|
72.2
CHF
|
+0.84%
|
|
+0.84%
|
+41.85%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
1,169
|
1,033
|
1,133
|
1,067
|
1,013
|
1,189
|
1,189
|
-
|
Enterprise Value (EV)
1 |
978.1
|
929.6
|
1,088
|
1,014
|
945.3
|
831.9
|
1,079
|
994.8
|
P/E ratio
|
-65
x
|
-42.3
x
|
-143
x
|
49.2
x
|
58.9
x
|
771
x
|
10.2
x
|
8.29
x
|
Yield
|
-
|
-
|
-
|
-
|
1.7%
|
3.65%
|
2.83%
|
1.23%
|
Capitalization / Revenue
|
17.8
x
|
16.5
x
|
18.6
x
|
16.4
x
|
9.92
x
|
9.1
x
|
4.54
x
|
4.92
x
|
EV / Revenue
|
14.9
x
|
14.9
x
|
17.9
x
|
15.6
x
|
9.26
x
|
8.6
x
|
4.12
x
|
4.11
x
|
EV / EBITDA
|
-80.6
x
|
-142
x
|
84.1
x
|
54.8
x
|
22.6
x
|
31.4
x
|
6.18
x
|
6.8
x
|
EV / FCF
|
-81.1
x
|
-44.1
x
|
123
x
|
142
x
|
32.9
x
|
25
x
|
11.5
x
|
7.76
x
|
FCF Yield
|
-1.23%
|
-2.27%
|
0.81%
|
0.7%
|
3.04%
|
4%
|
8.68%
|
12.9%
|
Price to Book
|
2.61
x
|
2.6
x
|
2.83
x
|
2.09
x
|
2.2
x
|
2.06
x
|
2.31
x
|
1.98
x
|
Nbr of stocks (in thousands)
|
15,002
|
14,623
|
14,463
|
16,838
|
16,384
|
16,053
|
16,053
|
-
|
Reference price
2 |
77.95
|
70.64
|
78.34
|
63.36
|
61.81
|
74.09
|
74.09
|
74.09
|
Announcement Date
|
3/29/19
|
4/3/20
|
3/26/21
|
3/23/22
|
3/23/23
|
3/20/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
65.62
|
62.5
|
60.95
|
65.07
|
102.1
|
96.72
|
261.9
|
241.9
|
EBITDA
1 |
-12.14
|
-6.552
|
12.94
|
18.5
|
41.91
|
26.49
|
174.6
|
146.3
|
EBIT
1 |
-16.62
|
-12.31
|
6.905
|
11.1
|
28.06
|
12.23
|
158.1
|
128.1
|
Operating Margin
|
-25.33%
|
-19.69%
|
11.33%
|
17.06%
|
27.48%
|
12.64%
|
60.38%
|
52.94%
|
Earnings before Tax (EBT)
1 |
-17.46
|
-21.3
|
-6.931
|
24
|
24.47
|
7.611
|
162.5
|
149.9
|
Net income
1 |
-18.06
|
-24.49
|
-7.901
|
21.67
|
17.22
|
1.147
|
111
|
102.1
|
Net margin
|
-27.52%
|
-39.19%
|
-12.96%
|
33.31%
|
16.87%
|
1.19%
|
42.38%
|
42.19%
|
EPS
2 |
-1.200
|
-1.669
|
-0.5460
|
1.287
|
1.049
|
0.0710
|
7.280
|
8.935
|
Free Cash Flow
1 |
-12.06
|
-21.09
|
8.865
|
7.124
|
28.71
|
33.31
|
93.7
|
128.3
|
FCF margin
|
-18.38%
|
-33.75%
|
14.54%
|
10.95%
|
28.12%
|
34.44%
|
35.78%
|
53.01%
|
FCF Conversion (EBITDA)
|
-
|
-
|
68.51%
|
38.51%
|
68.5%
|
125.76%
|
53.65%
|
87.66%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
32.87%
|
166.68%
|
2,904.1%
|
84.41%
|
125.66%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
1.050
|
2.000
|
2.100
|
0.9128
|
Announcement Date
|
3/29/19
|
4/3/20
|
3/26/21
|
3/23/22
|
3/23/23
|
3/20/24
|
-
|
-
|
Fiscal Period: December |
2019 S1
|
2019 S2
|
2020 S1
|
2021 S1
|
2022 S1
|
2022 S2
|
2023 S1
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 S2
|
---|
Net sales
1 |
21.51
|
40.99
|
25.88
|
28.42
|
41.51
|
60.58
|
43.66
|
131.3
|
35.8
|
142.5
|
42.8
|
113.9
|
EBITDA
|
-
|
8.041
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-17.2
|
4.894
|
2.662
|
0.008
|
8.108
|
19.95
|
7.123
|
108.3
|
11.1
|
94.6
|
15.44
|
66.9
|
Operating Margin
|
-79.98%
|
11.94%
|
10.28%
|
0.03%
|
19.53%
|
32.93%
|
16.31%
|
82.49%
|
30.99%
|
66.39%
|
36.07%
|
58.74%
|
Earnings before Tax (EBT)
|
-22.62
|
1.315
|
-5.331
|
-4.667
|
9.089
|
15.38
|
3.673
|
-
|
-
|
95
|
-
|
67.5
|
Net income
|
-20.78
|
-3.712
|
-3.015
|
-5.741
|
7.896
|
9.329
|
1.486
|
-
|
-
|
68.4
|
-
|
48.6
|
Net margin
|
-96.63%
|
-9.06%
|
-11.65%
|
-20.2%
|
19.02%
|
15.4%
|
3.4%
|
-
|
-
|
48%
|
-
|
42.67%
|
EPS
|
-1.407
|
-0.2620
|
-0.2080
|
-0.3990
|
0.4760
|
0.5730
|
0.0920
|
-
|
-
|
4.260
|
-
|
3.020
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
7/30/19
|
4/3/20
|
7/30/20
|
7/30/21
|
7/28/22
|
3/23/23
|
7/26/23
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
191
|
103
|
44.7
|
52.3
|
67.4
|
48.4
|
110
|
195
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-12.1
|
-21.1
|
8.87
|
7.12
|
28.7
|
33.3
|
93.7
|
128
|
ROE (net income / shareholders' equity)
|
-3.95%
|
-5.83%
|
-
|
-
|
3.58%
|
0.26%
|
22.1%
|
18.8%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
29.90
|
27.10
|
27.70
|
30.20
|
28.10
|
26.60
|
32.00
|
37.50
|
Cash Flow per Share
2 |
-0.6800
|
-
|
0.9000
|
0.7500
|
2.020
|
2.090
|
5.780
|
2.920
|
Capex
1 |
1.9
|
2.25
|
4.12
|
-
|
4.52
|
3.35
|
9.9
|
6.89
|
Capex / Sales
|
2.89%
|
3.59%
|
6.76%
|
-
|
4.42%
|
3.46%
|
3.78%
|
2.85%
|
Announcement Date
|
3/29/19
|
4/3/20
|
3/26/21
|
3/23/22
|
3/23/23
|
3/20/24
|
-
|
-
|
Last Close Price
74.09
EUR Average target price
94.95
EUR Spread / Average Target +28.16% Consensus |
1st Jan change
|
Capi.
|
---|
| +41.85% | 1.28B | | +26.08% | 662B | | +21.85% | 546B | | -4.77% | 359B | | +16.97% | 323B | | +5.69% | 290B | | +13.68% | 234B | | +3.65% | 198B | | -11.12% | 194B | | -3.40% | 157B |
Other Pharmaceuticals
|